HK1047578B - 維生素d3類似物 - Google Patents

維生素d3類似物

Info

Publication number
HK1047578B
HK1047578B HK02109178.3A HK02109178A HK1047578B HK 1047578 B HK1047578 B HK 1047578B HK 02109178 A HK02109178 A HK 02109178A HK 1047578 B HK1047578 B HK 1047578B
Authority
HK
Hong Kong
Prior art keywords
analogs
vitamin
Prior art date
Application number
HK02109178.3A
Other languages
English (en)
Other versions
HK1047578A1 (en
Inventor
安德魯‧戴維‧巴超
伯納德‧邁克爾‧亨尼西
米蘭‧拉多耶‧烏斯科科維奇
Original Assignee
霍夫曼-拉羅奇有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 霍夫曼-拉羅奇有限公司 filed Critical 霍夫曼-拉羅奇有限公司
Publication of HK1047578A1 publication Critical patent/HK1047578A1/xx
Publication of HK1047578B publication Critical patent/HK1047578B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02109178.3A 1999-07-12 2002-12-18 維生素d3類似物 HK1047578B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12
PCT/EP2000/006393 WO2001004089A1 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs

Publications (2)

Publication Number Publication Date
HK1047578A1 HK1047578A1 (en) 2003-02-28
HK1047578B true HK1047578B (zh) 2005-04-29

Family

ID=22503954

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02109178.3A HK1047578B (zh) 1999-07-12 2002-12-18 維生素d3類似物

Country Status (36)

Country Link
US (1) US6331642B1 (zh)
EP (1) EP1200399B1 (zh)
JP (1) JP3803579B2 (zh)
KR (1) KR100477161B1 (zh)
CN (1) CN1174964C (zh)
AR (1) AR024695A1 (zh)
AT (1) ATE262508T1 (zh)
AU (1) AU779408B2 (zh)
BR (1) BR0012419A (zh)
CA (1) CA2378803C (zh)
CO (1) CO5190683A1 (zh)
DE (1) DE60009303T2 (zh)
DK (1) DK1200399T3 (zh)
EG (1) EG23909A (zh)
ES (1) ES2215707T3 (zh)
GC (1) GC0000198A (zh)
HK (1) HK1047578B (zh)
HR (1) HRP20020007A2 (zh)
HU (1) HUP0202157A3 (zh)
IL (2) IL147254A0 (zh)
JO (1) JO2255B1 (zh)
MA (1) MA26808A1 (zh)
MX (1) MXPA02000313A (zh)
MY (1) MY122633A (zh)
NO (1) NO20020161D0 (zh)
NZ (1) NZ516339A (zh)
PE (1) PE20010328A1 (zh)
PL (1) PL201877B1 (zh)
PT (1) PT1200399E (zh)
RS (1) RS50229B (zh)
RU (1) RU2235721C2 (zh)
TR (1) TR200200054T2 (zh)
TW (1) TWI268276B (zh)
UY (1) UY26239A1 (zh)
WO (1) WO2001004089A1 (zh)
ZA (1) ZA200110487B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
EP1330459B1 (en) 2000-10-02 2006-08-02 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
CA2459789A1 (en) * 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
AU2004235775A1 (en) * 2003-04-30 2004-11-18 Bioxell S.P.A. Gemini vitamin D3 compounds and methods of use thereof
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
AU2004203436A1 (en) * 2003-09-24 2005-04-14 Bioxell Spa Compound and use in treatment
EP1663250A4 (en) * 2003-09-24 2006-12-20 Bioxell Spa TREATMENT OF MALFUNCTION OF BLADDER
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
WO2008146130A1 (en) * 2007-05-30 2008-12-04 Cytochroma Inc. Process for producing phosphine oxide vitamin d precursors
DK2708559T3 (en) 2008-04-11 2018-06-14 Chugai Pharmaceutical Co Ltd Antigen-binding molecule capable of repeatedly binding two or more antigen molecules
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
HK1047578A1 (en) 2003-02-28
EG23909A (en) 2007-12-30
UY26239A1 (es) 2000-10-31
PL356124A1 (en) 2004-06-14
RU2235721C2 (ru) 2004-09-10
GC0000198A (en) 2006-03-29
DK1200399T3 (da) 2004-07-19
RS50229B (sr) 2009-07-15
PT1200399E (pt) 2004-06-30
BR0012419A (pt) 2002-03-26
HUP0202157A3 (en) 2004-04-28
MA26808A1 (fr) 2004-12-20
CA2378803A1 (en) 2001-01-18
NO20020161L (no) 2002-01-11
MXPA02000313A (es) 2002-06-21
AR024695A1 (es) 2002-10-23
DE60009303D1 (de) 2004-04-29
DE60009303T2 (de) 2005-02-24
ZA200110487B (en) 2003-03-20
PL201877B1 (pl) 2009-05-29
IL147254A (en) 2006-07-05
TWI268276B (en) 2006-12-11
CN1174964C (zh) 2004-11-10
TR200200054T2 (tr) 2002-06-21
CN1360572A (zh) 2002-07-24
EP1200399B1 (en) 2004-03-24
NZ516339A (en) 2003-07-25
US6331642B1 (en) 2001-12-18
HRP20020007A2 (en) 2003-04-30
AU779408B2 (en) 2005-01-20
MY122633A (en) 2006-04-29
ATE262508T1 (de) 2004-04-15
HUP0202157A2 (en) 2002-10-28
ES2215707T3 (es) 2004-10-16
KR20020033728A (ko) 2002-05-07
WO2001004089A1 (en) 2001-01-18
CO5190683A1 (es) 2002-08-29
PE20010328A1 (es) 2001-03-22
NO20020161D0 (no) 2002-01-11
AU6689400A (en) 2001-01-30
JO2255B1 (en) 2004-10-07
JP2003504354A (ja) 2003-02-04
JP3803579B2 (ja) 2006-08-02
YU92701A (sh) 2004-09-03
CA2378803C (en) 2009-01-27
IL147254A0 (en) 2002-08-14
EP1200399A1 (en) 2002-05-02
KR100477161B1 (ko) 2005-03-18

Similar Documents

Publication Publication Date Title
PL347548A1 (en) Vitamin d analogues
AU7895601A (en) Stabilized 1alpha-hydroxy vitamin d
GB9914222D0 (en) Pharmeceutical compounds
TW587632U (en) Elevator
PL364768A1 (en) Vitamin d analogues
HK1040690A1 (en) Elevator arrangement
SG70009A1 (en) Vitamin d3 analogs
GC0000198A (en) Vitamin d3 analogs
GB9906457D0 (en) Anti-oxidant
PL355432A1 (en) Vitamin d analogues
EP1174383A4 (en) ESCALATOR
EP1275643A4 (en) DERIVATIVES OF VITAMIN D
AU140483S (en) Outsole
ZA9811460B (en) Novel vitamin d3 derivatives
IL146184A0 (en) Antioxidative vitamin b6 analogs
AU6550800A (en) Hepoxilin analogs
SI1200399T1 (en) Vitamin d3 analogs
PL356301A1 (en) Novel vitamin d analogues
GB9916950D0 (en) Walkway
AU2337801A (en) Angiopoietin analogs
GB9905498D0 (en) Expression
TW520740U (en) Escalator
AU2291600A (en) New vitamin d analogs
GB9924096D0 (en) Supplement
GB9907749D0 (en) Elevator

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100706